AI for more precise radiation therapy
Learn how artificial intelligence is changing radiation therapy.
Gilead joins Oslo Cancer Cluster
Gilead is a biopharmaceutical company advancing innovative medicines
Polygenic risk scores: a European cancer priority
Polygenic risk scores can improve prevention and early detection of cancer.
New targeted therapy against osteosarcoma
Research group in Oslo Cancer Cluster Incubator develops new cancer treatment
Oncology innovators presented in Boston
Three Nordic start-ups pitched at the International Cancer Cluster Showcase 2023. This year’s International Cancer Cluster Showcase (ICCS) featured 20 emerging oncology companies that presented their recent innovations, partnering and investment opportunities on 5 June 2023 in Boston, as a satellite event to BIO International Convention. The companies were selected by innovation hubs in the […]
Cancer start-ups met investors
Investors wanted to learn about Norwegian cancer companies.
